Cite
ASO targeting RBM3 temperature‐controlled poison exon splicing prevents neurodegeneration in vivo
MLA
Marco Preußner, et al. “ASO Targeting RBM3 Temperature‐controlled Poison Exon Splicing Prevents Neurodegeneration in Vivo.” EMBO Molecular Medicine, vol. 15, no. 5, Mar. 2023, pp. 1–12. EBSCOhost, https://doi.org/10.15252/emmm.202217157.
APA
Marco Preußner, Heather L Smith, Daniel Hughes, Min Zhang, Ann‐Kathrin Emmerichs, Silvia Scalzitti, Diego Peretti, Dean Swinden, Alexander Neumann, Tom Haltenhof, Giovanna R Mallucci, & Florian Heyd. (2023). ASO targeting RBM3 temperature‐controlled poison exon splicing prevents neurodegeneration in vivo. EMBO Molecular Medicine, 15(5), 1–12. https://doi.org/10.15252/emmm.202217157
Chicago
Marco Preußner, Heather L Smith, Daniel Hughes, Min Zhang, Ann‐Kathrin Emmerichs, Silvia Scalzitti, Diego Peretti, et al. 2023. “ASO Targeting RBM3 Temperature‐controlled Poison Exon Splicing Prevents Neurodegeneration in Vivo.” EMBO Molecular Medicine 15 (5): 1–12. doi:10.15252/emmm.202217157.